Janssen Pharmaceuticals (Nucynta franchise)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Oral analgesic tablets for chronic pain in adults. The drug is an oral analgesic indicated for the management of moderate to severe chronic pain in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.
Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 1125 Trenton Harbourton Road
- 1125 Trenton-Harbourton Road
- Hopewell Township, NJ 08560
- United States
Janssen Pharmaceuticals (Nucynta franchise) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Janssen Pharmaceuticals (Nucynta franchise)‘s full profile, request access.
Request full access to PitchBookJanssen Pharmaceuticals (Nucynta franchise) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Janssen Pharmaceuticals (Nucynta franchise)‘s full profile, request access.
Request full access to PitchBook